Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 2, 2007
Diabetes Care 30:1430-1436, 2007
DOI: 10.2337/dc06-1820
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum (v31,p187)
Right arrow All Versions of this Article:
dc06-1820v1
30/6/1430    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheung, B. M.Y.
Right arrow Articles by Lam, K. S.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheung, B. M.Y.
Right arrow Articles by Lam, K. S.L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Epidemiology/Health Services/Psychosocial Research
Original Article

Development of Diabetes in Chinese With the Metabolic Syndrome

A 6-year prospective study

Bernard M.Y. Cheung, PHD1, Nelson M.S. Wat, FRCP1, Yu Bun Man, MPHIL1, Sidney Tam, FACB2, G. Neil Thomas, PHD3, Gabriel M. Leung, MD3, Chun Ho Cheng, FRCP1, Jean Woo, MD4, Edward D. Janus, MD5, Chu Pak Lau, MD1, Tai Hing Lam, MD3 and Karen S.L. Lam, MD1

1 Department of Medicine, University of Hong Kong, Hong Kong, China
2 Department of Clinical Biochemistry Unit, Queen Mary Hospital, Hong Kong, China
3 Department of Community Medicine, University of Hong Kong, Hong Kong, China
4 Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China
5 Department of Medicine, University of Melbourne, Western Hospital, Footscray, Victoria, Australia

Address correspondence and reprint requests to Prof. Bernard M.Y. Cheung, University Department of Medicine, Queen Mary Hospital, Pokfulam, Hong Kong, China. E-mail: mycheung{at}hkucc.hku.hk

OBJECTIVE—We investigated the association of the metabolic syndrome with new-onset diabetes in the Hong Kong Cardiovascular Risk Factor Prevalence Study cohort.

RESEARCH DESIGN AND METHODS—We followed up on 1,679 subjects without diabetes at baseline. Those with a previous diagnosis of diabetes or those who were receiving drug treatment were considered to be diabetic. The remaining subjects underwent a 75-g oral glucose tolerance test (OGTT). Diabetes was defined by plasma glucose ≥7.0 mmol/l with fasting and/or ≥11.1 mmol/l at 2 h.

RESULTS—The prevalences of the metabolic syndrome at baseline were 14.5 and 11.4%, respectively, according to U.S. National Cholesterol Education Program (NCEP) and International Diabetes Federation (IDF) criteria. After a median of 6.4 years, there were 66 and 54 new cases of diabetes in men and women, respectively. The metabolic syndrome at baseline predicted incident diabetes. Hazard ratios (HRs) for the NCEP and IDF definitions of the syndrome were 4.1 [95% CI 2.8–6.0] and 3.5 [2.3–5.2], respectively. HRs for fasting plasma glucose (FPG) ≥6.1 or 5.6 mmol/l were 6.9 [4.1–11.5] and 4.1 [2.8–6.0], respectively. The NCEP and IDF criteria had 41.9 and 31.7% sensitivity and 87.5 and 90.2% specificity, respectively. Their positive predictive values were low, ~20%, but their negative predictive values were ~95%.

CONCLUSIONS—The metabolic syndrome, particularly its component, elevated FPG, predicts diabetes in Chinese. An individual without the metabolic syndrome is unlikely to develop diabetes, but one who has it should practice therapeutic lifestyle changes and have periodic FPG measurements to detect new-onset diabetes.

Abbreviations: CRISPS, Hong Kong Cardiovascular Risk Factor Prevalence Study • FPG, fasting plasma glucose • IDF, International Diabetes Federation • IFG, impaired fasting glucose • HOMA-IR, homeostasis model assessment estimate of insulin resistance • NCEP, National Cholesterol Education Program • OGTT, oral glucose tolerance test • ROC, receiver operating characteristic


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
B. M.Y. Cheung, N. M.S. Wat, A. W.K. Tso, S. Tam, G. N. Thomas, G. M. Leung, H. F. Tse, J. Woo, E. D. Janus, C. P. Lau, et al.
Association Between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care, September 1, 2008; 31(9): 1889 - 1891.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
C. C. Leung, T. H. Lam, W. M. Chan, W. W. Yew, K. S. Ho, G. M. Leung, W. S. Law, C. M. Tam, C. K. Chan, and K. C. Chang
Diabetic Control and Risk of Tuberculosis: A Cohort Study
Am. J. Epidemiol., June 15, 2008; 167(12): 1486 - 1494.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.